EGFR and breast cancer: Recently, using insertion mutagenesis in an estrogen-dependent breast carcinoma cell line, a panel of 7 candidate breast cancer anti-estrogen resistant (BCAR) genes were identified that directly underlie estrogen independence leading to tamoxifen resistance, including both EGFR, AKT1, and AKT2 [59].